ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Company to seek approval of oral testosterone undecanoate in the United States
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 10193" data-attributes="member: 3"><p>This company is seeking approval of a product already available in Canada as an oral agent to increase testosterone (testosterone undecanoate, the same active agent that Aveed or Nebido contains). This product needs to be taken more than once a day.</p><p></p><p></p><p><a href="http://www.google.com/url?sa=t&rct=j&q=clarus%20therapeutics&source=web&cd=1&cad=rja&uact=8&ved=0CB8QFjAA&url=http%3A%2F%2Fwww.clarustherapeutics.com%2F&ei=FN_oU6eXB6a58gG5uoCQAw&usg=AFQjCNELee9qqocz77bpEhk28eqY9dktoA&sig2=DVkVHnNPKSKtbV5iSblTyg" target="_blank">Clarus Therapeutics, Inc.</a> recently presented phase III clinical data from two studies that it says support the safety and efficacy of oral <a href="http://www.modernmedicine.com/taxonomy/term/4564" target="_blank">testosterone</a> undecanoate (REXTORO) for testosterone replacement therapy in men with hypogonadism. Each trial differed in design, dose-titration algorithm, and duration. Each demonstrated T replacement, and with the revised dose-titration algorithm, the maximum serum T concentration was comparable to other T replacement therapies. The agent met the efficacy endpoint in both studies, said Clarus Therapeutics CEO Robert E. Dudley, PhD, in a press release. The studies were presented at the International Congress of Endocrinology and the Endocrine Society’s Annual Meeting and Expo in Chicago.- See more at: <a href="http://urologytimes.modernmedicine.com/urology-times/news/urology-product-preview-testosterone-agent-meets-efficacy-endpoint-phase-iii-stud#sthash.oztUUa4e.dpuf" target="_blank">http://urologytimes.modernmedicine.com/urology-times/news/urology-product-preview-testosterone-agent-meets-efficacy-endpoint-phase-iii-stud#sthash.oztUUa4e.dpuf</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 10193, member: 3"] This company is seeking approval of a product already available in Canada as an oral agent to increase testosterone (testosterone undecanoate, the same active agent that Aveed or Nebido contains). This product needs to be taken more than once a day. [URL="http://www.google.com/url?sa=t&rct=j&q=clarus%20therapeutics&source=web&cd=1&cad=rja&uact=8&ved=0CB8QFjAA&url=http%3A%2F%2Fwww.clarustherapeutics.com%2F&ei=FN_oU6eXB6a58gG5uoCQAw&usg=AFQjCNELee9qqocz77bpEhk28eqY9dktoA&sig2=DVkVHnNPKSKtbV5iSblTyg"]Clarus Therapeutics, Inc.[/URL] recently presented phase III clinical data from two studies that it says support the safety and efficacy of oral [URL="http://www.modernmedicine.com/taxonomy/term/4564"]testosterone[/URL] undecanoate (REXTORO) for testosterone replacement therapy in men with hypogonadism. Each trial differed in design, dose-titration algorithm, and duration. Each demonstrated T replacement, and with the revised dose-titration algorithm, the maximum serum T concentration was comparable to other T replacement therapies. The agent met the efficacy endpoint in both studies, said Clarus Therapeutics CEO Robert E. Dudley, PhD, in a press release. The studies were presented at the International Congress of Endocrinology and the Endocrine Society’s Annual Meeting and Expo in Chicago.- See more at: [url]http://urologytimes.modernmedicine.com/urology-times/news/urology-product-preview-testosterone-agent-meets-efficacy-endpoint-phase-iii-stud#sthash.oztUUa4e.dpuf[/url] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Company to seek approval of oral testosterone undecanoate in the United States
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top